Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
NCT06589518Phase 2Not yet recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tenofovir alafenamide in hepatitis B (HBV). Planned start Mar 2025; status: not yet recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT06589518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06589518.